Postoperative Adjuvant Therapy Benefits Non‐<scp>pCR</scp> Patients Rather Than <scp>pCR</scp> Patients for Locally Advanced <scp>ESCC</scp>: A Multicenter Real‐World Study
Postoperative AT benefited ESCC patients with non-pCR, while AICT may be a relatively better AT regimen in real-world data, which deserves further exploration.
Authors
- Yuanlin Li (ORCID: https://orcid.org/0000-0001-5466-6164)
- Defeng Liu (ORCID: https://orcid.org/0000-0001-6751-1399)
- Haiqun Lin (ORCID: https://orcid.org/0000-0002-3114-9671)
- Ao Liu (ORCID: https://orcid.org/0000-0003-4833-5718)
- Yi Li (ORCID: https://orcid.org/0000-0001-8643-4501)
- Jinming Yu (ORCID: https://orcid.org/0000-0001-5933-9912)
- Minghuan Li (ORCID: https://orcid.org/0000-0001-6112-7038)
- Longxiang Guo
- Yuxiang Chi
Institutions
- Shandong University (CN)
- Wenzhou Medical University (CN)
- Shandong Tumor Hospital (CN)
- Second Hospital of Shandong University (CN)
- Shandong Provincial Hospital (CN)
- Dongyang People's Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/1759-7714.70021
- Citations
- 4
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- National Natural Science Foundation of China